Last C$0.04 CAD
Change Today -0.005 / -11.11%
Volume 50.0K
CVN On Other Exchanges
As of 3:21 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

cavan ventures inc (CVN) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/24/13 - C$0.09
52 Week Low
11/18/13 - C$0.03
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CAVAN VENTURES INC (CVN)

Related News

No related news articles were found.

cavan ventures inc (CVN) Related Businessweek News

No Related Businessweek News Found

cavan ventures inc (CVN) Details

Cavan Ventures Inc., a junior mining company, engages in the acquisition and exploration of mineral properties in North America. The company explores for graphite, gold, and rare earth deposits. It owns interests in various properties located in Quebec, Saskatchewan, and Ontario Canada. The company was incorporated in 2006 and is based in Vancouver, Canada.

Founded in 2006

cavan ventures inc (CVN) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: --
Chief Financial Officer
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

cavan ventures inc (CVN) Key Developments

Cavan Receives Positive Trenching Assays at Buckingham Graphite Property, Quebec

Cavan Ventures Inc. announced exceptional assays for graphite-rich zones as a result of trenching on its 100%-owned Buckingham graphite property, located adjacent to the historic Walker Graphite Mine in Buckingham Township, Quebec. Graphite-rich zones were channel-sampled from four trenches, with results returning up to 17.8% C(org) (Organic Carbone) over 5.5 meters, 8.20% C(org) over 4.75 meters, 12.10% C(org) over 4.0 meters and 12.3% C(org) over 3.5 meters. In May, the Company engaged Magnor Exploration Inc. (La Baie, QC) to conduct an exploration work program, which included ground-based geophysics that was used to resolve airborne EM anomalies identified last year. With the help of a hydraulic shovel, six trenches ranging from four to 48 meters in length and two meters in width were completed. Trench 22C was cut for 24 meters in a northwest direction, with a second perpendicular trench cut at its southeast end for 20.5 meters. Graphite-rich zones were exposed in both trenches and channel-sampled with a rock saw over lengths from 0.50-1.25 meters and widths at 11.5 centimeters. In the southwest trenches, the sample returned 17.8% C(org) over 5.5 meters with two additional samples returning 1.21 % C(org) and 1.57% C(org) over 1.25 meters each. On the northeast trenches, a channel sample 0.50 meters in length returned 19.5% C(org), two additional samples assayed at 17.9% and 4.53% C(org) over 1.25 meters each, with a fourth channel returning 22.8% C(org) over 5.4 meters. The second trench is located 80 meters west-southwest of Trench 22C, and oriented in a west-northwest direction. The trench has an angle of about 35deg with the EM conductor axis and the stratigraphy. The excavation exposed visible graphite that was channel-sampled over 25.6 meters at 1.25 meter intervals, with individual intervals ranging from 0.35% C(org) to 16.7% C(org). The central part of the trench was not sampled but showed large disseminated graphite flakes. The high results from west to east are 8.20% C(org) over 4.75 meters, 12.10% C(org) over 4.0 meters and 12.3% C(org) over 3.5 meters. This mineralization is open to the west with the EM conductor also becoming much stronger to the southwest. A new graphite zone was also discovered roughly 150 meters northeast of Trench 22C, where granitic-pegmatitic rocks contain graphite-rich veins. A grab sample of one 5cm-thick vein returned 86.5% C(org) with flakes over 5mm in diameter.

Cavan Ventures Inc. Auditor Raises 'Going Concern' Doubt

Cavan Ventures Inc. filed its Annual on Jun 30, 2014 for the period ending Feb 28, 2014. In this report its auditor, Davidson & Company, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Cavan Ventures Inc. Appoints Manju Sharma to Advisory Board

Cavan Ventures Inc. previously announced the diversification of its growth plan into the Medical Marijuana and Hemp industry. To accelerate this process, Dr. Manju Sharma has joined the company as its newest member to the advisory board. Dr. Manju Sharma is a medical doctor, working currently as a scientist at Vancouver Prostate Centre, Vancouver General Hospital for the last 5 years. Prior to this she worked in the department of Pathology and Lab Medicine, VGH for 10 years.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CVN:CN C$0.04 CAD -0.005

CVN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CVN.
View Industry Companies

Industry Analysis


Industry Average

Valuation CVN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 2.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CAVAN VENTURES INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at